1. Home
  2. BBW vs FTH Comparison

BBW vs FTH Comparison

Compare BBW & FTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Build-A-Bear Workshop Inc.

BBW

Build-A-Bear Workshop Inc.

SELL

Current Price

$28.89

Market Cap

473.7M

ML Signal

SELL

Logo Faeth Therapeutics Inc. Common Stock

FTH

Faeth Therapeutics Inc. Common Stock

HOLD

Current Price

$9.06

Market Cap

507.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBW
FTH
Founded
1997
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
473.7M
507.8M
IPO Year
2004
2021

Fundamental Metrics

Financial Performance
Metric
BBW
FTH
Price
$28.89
$9.06
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
15
Target Price
$45.00
★ $56.15
AVG Volume (30 Days)
377.3K
★ 673.9K
Earning Date
12-03-2026
11-03-2026
Dividend Yield
★ 3.13%
N/A
EPS Growth
★ 5.00
N/A
EPS
★ 2.16
N/A
Revenue
★ $357,866,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.33
N/A
P/E Ratio
$13.62
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$23.19
$9.19
52 Week High
$72.19
$42.14

Technical Indicators

Market Signals
Indicator
BBW
FTH
Relative Strength Index (RSI) 53.76 24.72
Support Level $27.50 N/A
Resistance Level $39.94 $21.97
Average True Range (ATR) 1.50 1.92
MACD 0.05 -0.63
Stochastic Oscillator 52.01 3.73

Price Performance

Historical Comparison
BBW
FTH

About BBW Build-A-Bear Workshop Inc.

Build-A-Bear Workshop Inc is a U.S.-based specialty retailer of customized stuffed animals and related products. The company operates through three segments: Direct-to-consumer segment with key revenue, includes the operating activities of corporately-managed locations and other retail delivery operations in the U.S., Canada, U.K., Ireland, and two e-commerce sites, the international franchising segment includes royalties and product and fixture sales from other international operations under franchise agreements, and the commercial segment includes the transactions with other businesses, mainly comprised of licensing the intellectual properties for third-party use and wholesale activities.

About FTH Faeth Therapeutics Inc. Common Stock

Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.

Share on Social Networks: